A small wireless chip and a pair of smart glasses are offering new hope to people who thought they’d never read again. The ...

Today, in the New England Journal of Medicin e, researchers announced that they restored some vision to elderly patients with ...

The AMD pipeline presents opportunities via emerging novel therapies focusing on innovative mechanisms such as gene therapy, mitochondria-targeting peptides, and complement inhibition. Key drugs in ...

UB ophthalmologist Margaret DeAngelis leads work on the neurological condition that's the leading cause of blindness in ...

The device could help a million people with a severe form of macular degeneration to be able to see enough to read.

With AMD prevalence rising, key market opportunities include developing age-targeted therapies and strategic marketing in markets with the highest growth projections, like the US. Quantifying patient ...

Age-related macular degeneration is a common cause of vision loss, with existing treatments only able to slow its progression ...

A retinal implant developed by Science Corp. has for the first time restored some functional vision to patients with a severe ...

The treatment involves inserting a tiny implant thinner than human hair under the retina. Patients then have to wear glasses ...

The device helped people with an advanced form of age-related macular degeneration, which affects about 1 million people in ...

Researchers of the National Eye Institute found that the supplement—now known as the AREDS formula, containing vitamins C and ...

“Where this dead retina was a complete blind spot, vision was restored,” Dr. Frank Holz, the study’s lead author and an ...